MY101029A - Bromocriptine compositions - Google Patents

Bromocriptine compositions

Info

Publication number
MY101029A
MY101029A MYPI87001999A MYPI19871999A MY101029A MY 101029 A MY101029 A MY 101029A MY PI87001999 A MYPI87001999 A MY PI87001999A MY PI19871999 A MYPI19871999 A MY PI19871999A MY 101029 A MY101029 A MY 101029A
Authority
MY
Malaysia
Prior art keywords
bromocriptine
pharmaceutically acceptable
compositions
bromocriptine compositions
oral administration
Prior art date
Application number
MYPI87001999A
Inventor
Norman Mazer Dr
Zuger Othmar
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848405227A external-priority patent/GB8405227D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY101029A publication Critical patent/MY101029A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A CONTROLLED RELEASE FORMULATION FOR ORAL ADMINISTRATION COMPRISING .- BROMOCRIPTINE .-A PHARMACEUTICALLY ACCEPTABLE HYDROPHILIC SWELLING SUBSTANCE. -A PHARMACEUTICALLY ACCEPTABLE INERT FATTY MATERIAL.
MYPI87001999A 1984-02-29 1987-09-28 Bromocriptine compositions MY101029A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB08504788A GB2154874B (en) 1984-02-29 1985-02-25 Bromoscriptine compositions

Publications (1)

Publication Number Publication Date
MY101029A true MY101029A (en) 1991-06-29

Family

ID=26287383

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001999A MY101029A (en) 1984-02-29 1987-09-28 Bromocriptine compositions

Country Status (3)

Country Link
CY (1) CY1564A (en)
GB (1) GB2154874B (en)
MY (1) MY101029A (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
IT1235053B (en) * 1989-04-07 1992-06-17 Poli Ind Chimica Spa METHODS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON BROMOCRIPTINE EQUIPPED WITH HIGH STABILITY AND DERIVING PRODUCTS.
FR2656525A1 (en) * 1989-12-29 1991-07-05 Delalande Sa Controlled-release pharmaceutical dosage forms and process for manufacturing them
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
CN104013971B (en) * 2014-06-23 2017-09-26 深圳翰宇药业股份有限公司 A kind of bromocriptine composition sustained-release preparation and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
GB2154874A (en) 1985-09-18
GB2154874B (en) 1987-11-04
CY1564A (en) 1991-05-17
GB8504788D0 (en) 1985-03-27

Similar Documents

Publication Publication Date Title
MY101029A (en) Bromocriptine compositions
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
AU555061B2 (en) Sustained release oral medicinal delivery device
AU553010B2 (en) Device for active ingredient release
AU558331B2 (en) Solid medicament formulations containing nifedipine, and processes for their preparation
AU561144B2 (en) Foam composition for dentistry
AU8298287A (en) Transdermal contraceptive formulations
AU3326289A (en) Matrix for release of active ingredients
GB2120937B (en) Implant for sustained release of pharmaceutical agents
DE3571924D1 (en) Dosage units for controlled release of active material
AU1336288A (en) Photopolymerizable dental composition
AU2726088A (en) Ampule for controlled administration of beneficial agent
AU2027288A (en) Erythromycin formulations for oral administration
AU1604488A (en) Photopolymerizable dental composition
AU2617288A (en) Pharmaceutical formulations for transdermal administration
HK15695A (en) Solid oral administration forms containing ifosfamide as active agent
ES8705223A1 (en) Bromocriptine composition
AU562822B2 (en) Pharmaceutical composition of clotrimazole
AU1520788A (en) Photopolymerizable dental composition
JPS57209268A (en) Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one
DE3269449D1 (en) P-acylaminophenol derivatives with a therapeutical effect, process for their preparation, and compositions with a therapeutical effect containing these derivatives as pharmacologically active ingredients
HUT38353A (en) Process for producing 7-oxo-4-thia-1-azabicyclo/3.2.0/hept-2-ene derivatives and pharmaceutical compositions containing them as active agents
AU8303687A (en) Composition for administration through a body cavity
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances
MY102906A (en) Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions